Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK

Summary: Impaired mitochondrial respiratory activity contributes to the development of insulin resistance in type 2 diabetes. Metformin, a first-line antidiabetic drug, functions mainly by improving patients’ hyperglycemia and insulin resistance. However, its mechanism of action is still not well un...

Full description

Bibliographic Details
Main Authors: Yu Wang, Hongying An, Ting Liu, Caolitao Qin, Hiromi Sesaki, Shaodong Guo, Sally Radovick, Mehboob Hussain, Akhil Maheshwari, Fredric E. Wondisford, Brian O’Rourke, Ling He
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124719312677
id doaj-242411f041ab47b787ea101323460470
record_format Article
spelling doaj-242411f041ab47b787ea1013234604702020-11-25T01:26:12ZengElsevierCell Reports2211-12472019-11-0129615111523.e5Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPKYu Wang0Hongying An1Ting Liu2Caolitao Qin3Hiromi Sesaki4Shaodong Guo5Sally Radovick6Mehboob Hussain7Akhil Maheshwari8Fredric E. Wondisford9Brian O’Rourke10Ling He11Division of Neonatology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADivision of Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADivision of Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADepartment of Nutrition and Food Science, Texas A&M University, TX 77843, USADepartments of Pediatrics and Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USADivision of Metabolism, Endocrinology and Diabetes, University of Michigan Medical School, Ann Arbor, MI 48105, USADivision of Neonatology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADepartments of Pediatrics and Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USADepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADivision of Neonatology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Division of Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Corresponding authorSummary: Impaired mitochondrial respiratory activity contributes to the development of insulin resistance in type 2 diabetes. Metformin, a first-line antidiabetic drug, functions mainly by improving patients’ hyperglycemia and insulin resistance. However, its mechanism of action is still not well understood. We show here that pharmacological metformin concentration increases mitochondrial respiration, membrane potential, and ATP levels in hepatocytes and a clinically relevant metformin dose increases liver mitochondrial density and complex 1 activity along with improved hyperglycemia in high-fat- diet (HFD)-fed mice. Metformin, functioning through 5′ AMP-activated protein kinase (AMPK), promotes mitochondrial fission to improve mitochondrial respiration and restore the mitochondrial life cycle. Furthermore, HFD-fed-mice with liver-specific knockout of AMPKα1/2 subunits exhibit higher blood glucose levels when treated with metformin. Our results demonstrate that activation of AMPK by metformin improves mitochondrial respiration and hyperglycemia in obesity. We also found that supra-pharmacological metformin concentrations reduce adenine nucleotides, resulting in the halt of mitochondrial respiration. These findings suggest a mechanism for metformin’s anti-tumor effects. : The mechanism of metformin action still remains controversial, in particular on mitochondrial activity and the involvement of AMPK. Wang et al. show that pharmacological metformin concentration or dose improves mitochondrial respiration by increasing mitochondrial fission through AMPK-Mff signaling; in contrast, supra-pharmacological metformin concentrations reduce mitochondrial respiration through decreasing adenine nucleotide levels. Keywords: metformin, diabetes, insulin resistance, mitochondrial respiration/fission, membrane potential, adenine nucleotides, AMPK, Drp1http://www.sciencedirect.com/science/article/pii/S2211124719312677
collection DOAJ
language English
format Article
sources DOAJ
author Yu Wang
Hongying An
Ting Liu
Caolitao Qin
Hiromi Sesaki
Shaodong Guo
Sally Radovick
Mehboob Hussain
Akhil Maheshwari
Fredric E. Wondisford
Brian O’Rourke
Ling He
spellingShingle Yu Wang
Hongying An
Ting Liu
Caolitao Qin
Hiromi Sesaki
Shaodong Guo
Sally Radovick
Mehboob Hussain
Akhil Maheshwari
Fredric E. Wondisford
Brian O’Rourke
Ling He
Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK
Cell Reports
author_facet Yu Wang
Hongying An
Ting Liu
Caolitao Qin
Hiromi Sesaki
Shaodong Guo
Sally Radovick
Mehboob Hussain
Akhil Maheshwari
Fredric E. Wondisford
Brian O’Rourke
Ling He
author_sort Yu Wang
title Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK
title_short Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK
title_full Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK
title_fullStr Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK
title_full_unstemmed Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK
title_sort metformin improves mitochondrial respiratory activity through activation of ampk
publisher Elsevier
series Cell Reports
issn 2211-1247
publishDate 2019-11-01
description Summary: Impaired mitochondrial respiratory activity contributes to the development of insulin resistance in type 2 diabetes. Metformin, a first-line antidiabetic drug, functions mainly by improving patients’ hyperglycemia and insulin resistance. However, its mechanism of action is still not well understood. We show here that pharmacological metformin concentration increases mitochondrial respiration, membrane potential, and ATP levels in hepatocytes and a clinically relevant metformin dose increases liver mitochondrial density and complex 1 activity along with improved hyperglycemia in high-fat- diet (HFD)-fed mice. Metformin, functioning through 5′ AMP-activated protein kinase (AMPK), promotes mitochondrial fission to improve mitochondrial respiration and restore the mitochondrial life cycle. Furthermore, HFD-fed-mice with liver-specific knockout of AMPKα1/2 subunits exhibit higher blood glucose levels when treated with metformin. Our results demonstrate that activation of AMPK by metformin improves mitochondrial respiration and hyperglycemia in obesity. We also found that supra-pharmacological metformin concentrations reduce adenine nucleotides, resulting in the halt of mitochondrial respiration. These findings suggest a mechanism for metformin’s anti-tumor effects. : The mechanism of metformin action still remains controversial, in particular on mitochondrial activity and the involvement of AMPK. Wang et al. show that pharmacological metformin concentration or dose improves mitochondrial respiration by increasing mitochondrial fission through AMPK-Mff signaling; in contrast, supra-pharmacological metformin concentrations reduce mitochondrial respiration through decreasing adenine nucleotide levels. Keywords: metformin, diabetes, insulin resistance, mitochondrial respiration/fission, membrane potential, adenine nucleotides, AMPK, Drp1
url http://www.sciencedirect.com/science/article/pii/S2211124719312677
work_keys_str_mv AT yuwang metforminimprovesmitochondrialrespiratoryactivitythroughactivationofampk
AT hongyingan metforminimprovesmitochondrialrespiratoryactivitythroughactivationofampk
AT tingliu metforminimprovesmitochondrialrespiratoryactivitythroughactivationofampk
AT caolitaoqin metforminimprovesmitochondrialrespiratoryactivitythroughactivationofampk
AT hiromisesaki metforminimprovesmitochondrialrespiratoryactivitythroughactivationofampk
AT shaodongguo metforminimprovesmitochondrialrespiratoryactivitythroughactivationofampk
AT sallyradovick metforminimprovesmitochondrialrespiratoryactivitythroughactivationofampk
AT mehboobhussain metforminimprovesmitochondrialrespiratoryactivitythroughactivationofampk
AT akhilmaheshwari metforminimprovesmitochondrialrespiratoryactivitythroughactivationofampk
AT fredricewondisford metforminimprovesmitochondrialrespiratoryactivitythroughactivationofampk
AT brianorourke metforminimprovesmitochondrialrespiratoryactivitythroughactivationofampk
AT linghe metforminimprovesmitochondrialrespiratoryactivitythroughactivationofampk
_version_ 1725110202946027520